Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Nigel Farage Faces Parliamentary Inquiry Over 5m Crypto Billionaire Gift Jim Cramer Warns SpaceX IPO Could Fuel Market Speculation Risking Broader Stability Via Transportation VIA Q1 2026 Earnings Beat Revenue NA EPS 005 The Billionaire AI Feud How Musk and Altmans OpenAI Alliance Crumbled in Court GDPs Flawed Gauge of Prosperity Spurs Push for Alternative Metrics Fed Rate Hike Expectations Resurface as Inflation Surge Fuels Market Pricing IDACORP Insider Files Form 144 for Potential Share Sale Princeton CorpGov Forum Explores Value Creation Plans in Private Equity Governance Bitcoin Slips to 74500 Set for Weekly Decline Amid Geopolitical Jitters AMD Commits Over 10 Billion to Taiwan AI Chip Infrastructure Expansion KEQU Q1 2026 Earnings EPS of 028 Reported Stock Edges Lower in Light Trading MGRB Q1 2026 Earnings EPS Beat Drives Modest Bond Price Uptick ADAMH Q1 2026 Earnings Senior Notes Trust Beats EPS Estimate by 75 Shares Edge Higher MDGL Q1 2026 Earnings Narrower Loss Surpasses Expectations Amid No Revenue Reported NRT Q2 2025 Earnings Trust Reports EPS of 020 Stock Advances 064 HFWA Q1 2026 Earnings Net Interest Margin Stability Drives Earnings Beat Manchester United Shares Slip Amid Performance Concerns OSR Holdings Inc OSRH Edges Lower as Stock Tests Key Support at 047 Marsh MRSH Holds Steady Near Support Mixed Signals Amid Modest Decline INEO Shares Drift Lower as Trading Volume Remains Subdued Gabelli Healthcare Wellness Trust GRX Edges Higher Amid Steady Trading FACT II Acquisition Corp Unit FACTU Holds Steady at 1145 as SPAC Market Awaits Catalyst Our Bond Inc OBAI Holds Steady at 045 as Support Level Holds RH RH Rallies 245 as Shares Test Resistance Near 149 American Public Education APEI Holds Steady Near 515 as Trading Activity Remains Calm Crane Harbor Acquisition Corp II Rights CRANR Slip 8 Key Support Retest in Focus Neurogene Inc NGNE Gains Ground as Biotech Names Eye Key Levels